Dicerna Pharmaceuticals Inc Revenue per Employee (DRNA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Dicerna Pharmaceuticals Inc   (NASDAQ: DRNA)
 

Dicerna Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Dicerna Pharmaceuticals Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,015,000, below the company average number of $402,973.
Within the Healthcare sector Employees of 39 other companies have achieved higher revenue per employee. While Dicerna Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 606. Dicerna Pharmaceuticals Inc has 190 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DRNA Revenue per Employee (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Revenue Change 28.81 % 2.2 % 39.89 % 478.47 % 508.28 %
Sales per Employee (TTM) $ 1,015,000 940,900 936,221 864,774 686,479
DRNA's Total Ranking # 606 # 0 # 0 # 0 # 0
Seq. Revenue Change 52.29 % -13.16 % 16.23 % -16.2 % 20.83 %

DRNA Company Profile >> Back to DRNA Efficiency Comparisons >> Compare DRNA Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 23
Healthcare Sector # 40
Overall Market # 606

Revenue per Employee Statistics
High Average Low
$ 1,015,000 $ 402,973 $ 26,221
(Sep 30 2021)   (Jun 30 2018)



Financial Statements
Dicerna Pharmaceuticals Inc 's Revenue MRQ $ 63 Millions Visit DRNA's Income Statement
Dicerna Pharmaceuticals Inc 's Revenues TTM $ 193 Millions Visit DRNA's aggregate revenue growth
What are DRNA's Sales? Visit DRNA's Sales by Segment




Other Ratios
Dicerna Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
DRNA's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for DRNA's Competitors
Revenue per Employee for DRNA's Suppliers
Revenue per Employee for DRNA's Customers

You may also want to know
DRNA's Sales Growth Rates DRNA's Pe Price to earnings ratio DRNA's Receivables Turnover Ratio DRNA's Stock Quote
DRNA's Net Income Growth Rates DRNA's Ps Price to Sales ratio DRNA's Sales per Employee DRNA's Asset Turnover Ratio
DRNA's Net Margin DRNA's Pb Price to Book ratio DRNA's Financial Strength Ratios DRNA's Dividend Payout Ratio
Date modified: 2026-09-08T15:10:25+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2021, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2021Number of Employees Sep 30 2021
Precision Biosciences Inc  1,735,823.53 $ 118.036  Million 68 
Semler Scientific inc   1,727,677.42 $ 53.558  Million 31 
Sorrento Therapeutics Inc   1,711,100.00 $ 51.333  Million 30 
Vyne Therapeutics Inc   1,674,900.00 $ 16.749  Million 10 
Gilead Sciences Inc   1,616,588.24 $ 27,482.000  Million 17,000 
Paratek Pharmaceuticals Inc   1,611,056.34 $ 114.385  Million 71 
Surface Oncology Inc   1,608,982.14 $ 90.103  Million 56 
Novavax inc   1,607,141.52 $ 1,203.749  Million 749 
Nektar Therapeutics  1,593,015.87 $ 100.360  Million 63 
Eagle Pharmaceuticals inc   1,531,128.21 $ 179.142  Million 117 
Biocept Inc   1,529,865.91 $ 65.784  Million 43 
Biogen Inc   1,480,066.67 $ 11,100.500  Million 7,500 
Seagen Inc   1,454,845.00 $ 1,745.814  Million 1,200 
Q32 Bio Inc   1,422,875.00 $ 34.149  Million 24 
Bristol myers Squibb Company  1,399,015.38 $ 45,468.000  Million 32,500 
Puma Biotechnology Inc   1,398,631.28 $ 250.355  Million 179 
Biohaven Ltd   1,287,071.13 $ 307.610  Million 239 
Acorda Therapeutics Inc   1,277,088.24 $ 130.263  Million 102 
Integrated Biopharma Inc  1,222,760.00 $ 61.138  Million 50 
United Therapeutics Corporation  1,182,285.71 $ 1,655.200  Million 1,400 
Anaptysbio Inc   1,174,653.85 $ 122.164  Million 104 
Siga Technologies Inc  1,143,725.71 $ 56.043  Million 49 
Bionexus Gene Lab Corp   1,130,406.53 $ 21.478  Million 19 
Halozyme Therapeutics Inc   1,094,586.29 $ 463.010  Million 423 
Exelixis Inc   1,093,183.96 $ 1,253.882  Million 1,147 
Akebia Therapeutics Inc   1,085,938.14 $ 210.672  Million 194 
Scienture Holdings Inc   1,055,092.11 $ 9.496  Million 9 
Incyte Corporation  1,024,234.53 $ 2,912.923  Million 2,844 
Endo International Plc  1,011,258.27 $ 2,963.998  Million 2,931 
Collegium Pharmaceutical Inc   1,000,787.23 $ 423.333  Million 423 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.